Salus BioMed
PrivateLast Round
Series A
Extension
May 14, 2025
Total Funding Raised
$13.9M
Momentum Score
25 /100
Company Overview
Salus BioMed is a life sciences company that provides a deoxyribonucleic acid (DNA) sequencing platform and develops high-definition spatial transcriptomics to measure gene activity, aiding in the diagnosis and treatment of diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotech Equipment, Biotechnology, Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Salus BioMed Comps
Public and private peers based on sector, stage, and business model.
Salus BioMed Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | May 14, 2025 | ||||
| Series A | Dec 1, 2023 | ||||
| Pre Seed | Oct 18, 2022 |
Salus BioMed Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BioTrack Capital | Series A |
| Qianhai Ark Asset Management | Series A |
| Shenzhen Capital Group | Series A Extension, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 27, 2026
Grew 31% QoQ from 16 to 21 employees.
- Apr 27, 2026
Grew 33% QoQ from 15 to 20 employees.
Salus BioMed Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Salus BioMed's valuation, stock price, and market status.
